New Wave Endo-Surgical | Top Endoscopic and Robotic Surgeries Technology 2026

MedTech Outlook Magazine

New Wave Endo-Surgical
The Next Evolution in Minimally Invasive Surgery

Alexander Gomez, New Wave Endo-Surgical | Medical Tech Outlook | Top Endoscopic and Robotic Surgeries TechnologyAlexander Gomez, CEO
What risks exist in trocar port-site closure during minimally invasive surgical procedures?

New Wave Endo-Surgical is solving one of minimally invasive surgery’s (MIS) most persistent and under-engineered risks— safe trocar port-site closure from inside the abdomen to prevent long-term complications like hernias and immediate catastrophic injuries. These small incisions, essential for laparoscopic and robotic procedures, are notoriously difficult to seal. Surgeons have to navigate with limited visualization, risking severe injuries like bowel perforations, visceral organ injuries, and vascular damage, issues that often go undetected during the operation especially at the procedure’s end when teams are fatigued.

This problem struck a chord with Alexander Gomez, CEO of New Wave Endo-Surgical, whose journey began with a personal invention, a defogging device used in millions of procedures worldwide. After selling that business to Medtronic, Gomez dedicated himself to working with medical professionals with innovative ideas. One such innovator was Dr. Manoj Patel, a passionate urologist who identified flaws in existing closure methods.

Tragically, Dr. Patel was diagnosed with leukemia at 48 and passed away within a year, leaving his concept unfinished. Moved by Patel’s vision to prevent patient suffering, Gomez reassembled his team to bring it to life, founding New Wave Endo-Surgical to deliver technologies that improve outcomes, reduce complications, and eliminate unnecessary postoperative opioid use.

From Blind Closure to Controlled Closure

How does the M-Close Kit improve safety and precision in trocar closure procedures?

The flagship product, M-Close Kit, born from Dr. Patel’s insights, is a tube-like device inserted through the port site after trocar removal. It deploys protective wings inside the abdomen, shielding organs from harm. The needles remain concealed throughout, allowing precise fascia penetration on both sides. Gomez emphasizes that this eliminates the trade-off; patients no longer choose between hernia prevention and injury risk. The process is repeatable and efficient, enabling quick suture placement even by trainees.

A perfect example is in obese patients, where traditional needles are nearly impossible to control. Bariatric and pediatric surgeons previously struggled, leading to inadequate closures and increased complications. With M-Close, even residents achieve reliable results, including extreme bariatric cases; closures that were once unfeasible now prevent hernias without added risk.

Along with protecting the needles, our device delivers local anesthetics into the deep tissue, reducing pain and opioid consumption.

Integrating Pain Management to Reduce Opioid Reliance

How does M-Close contribute to postoperative pain management and reduced opioid usage?

What further differentiates M-Close is its twofold role in pain control. Dr. Patel recognized the opioid epidemic’s roots in postoperative pain, often managed inadequately. The device uses its needles as guides to deliver local anesthetics deep into abdominal layers, like the rectus sheath, before suturing. Studies confirm that this leads to lower pain scores and opioid needs, especially in obese cases where traditional methods worsen issues. Priced at around $80, it remains accessible without compromising safety.

“Along with protecting the needles, our device delivers local anesthetics into the deep tissue, reducing pain and opioid consumption,” states Gomez.

Shaping the Future of Medtech Safety Standards

What future developments are planned to enhance safety in minimally invasive surgical procedures?

Moving forward, New Wave Endo-Surgical plans innovations in complementary accessories, addressing other procedural shortcomings while expanding M-Close for broader applications. Gomez’s focus remains ethical, pushing for protected-needle adoption to eliminate controllable risks, backed by peer-reviewed evidence of injuries, such as aortic lacerations, from exposed needles.

In a field where MIS volumes are rising, New Wave Endo-Surgical is improving more than individual surgical outcomes; it is reinforcing the sustainability of modern healthcare systems. As Gomez puts it, the mission is simple yet powerful—empowering surgeons to deliver better care, one closure at a time.

Deep Dive

Advancing Safer Closure in Endoscopic and Robotic Surgery

Minimally invasive surgery has shifted the standard of care toward smaller incisions, faster recovery and reduced trauma. That progress has introduced a less visible challenge at the final stage of procedures: closing access points created during laparoscopic and robotic interventions. While these entry sites appear minor, inadequate closure can......Read more

Endoscopic and Robotic Surgeries Technology Info

Q1

Why is New Wave Endo-Surgical recognized in the surgical technology market?

New Wave Endo-Surgical has established a specialized presence in the Endoscopic and Robotic Surgery Technologies sector through its focus on advanced surgical systems designed to support minimally invasive procedures. The company develops technologies intended to improve procedural precision, visualization and surgical efficiency within modern operating environments. Its approach to Endoscopic and Robotic Surgery Technologies emphasizes innovation, clinical usability and procedure-focused functionality aligned with evolving surgical care requirements. By concentrating on advanced surgical technology development, New Wave Endo-Surgical continues to strengthen its relevance within minimally invasive healthcare solutions.

Q2

What differentiates New Wave Endo-Surgical from other surgical technology providers?

Procedure-focused innovation and minimally invasive surgical support distinguish New Wave Endo-Surgical within the Endoscopic and Robotic Surgery Technologies category. The company develops systems intended to support greater procedural control, enhanced visualization and operational precision during surgical interventions. Its technology strategy emphasizes functionality, usability and alignment with modern surgical workflow demands rather than generalized healthcare equipment development. By focusing specifically on advanced surgical technologies, New Wave Endo-Surgical positions its solutions to support evolving clinical expectations within endoscopic and robotic procedures.

Q3

How does New Wave Endo-Surgical support healthcare professionals and surgical teams?

New Wave Endo-Surgical supports healthcare providers through Endoscopic and Robotic Surgery Technologies designed to improve surgical workflow efficiency and procedural support. The company emphasizes technology usability, clinical functionality and procedural consistency to assist surgical teams operating within complex treatment environments. Its focus on advanced visualization and minimally invasive procedure support contributes to more streamlined surgical experiences and dependable technology performance. This support-oriented approach helps strengthen confidence in surgical system integration and procedural execution.

Q4

How do New Wave Endo-Surgical’s technologies create value in surgical environments?

Precision, efficiency and minimally invasive treatment support contribute significantly to the value of New Wave Endo-Surgical’s Endoscopic and Robotic Surgery Technologies. The company’s systems are intended to support healthcare organizations seeking advanced procedural technologies capable of improving workflow consistency and surgical control. Attention to surgical usability and technology refinement also helps align its solutions with the operational priorities of modern healthcare facilities. Through its focus on advanced surgical systems, New Wave Endo-Surgical supports ongoing improvements in procedural performance and patient care technology.

Q5

What role does innovation play in New Wave Endo-Surgical’s development strategy?

Innovation remains central to New Wave Endo-Surgical’s work within the Endoscopic and Robotic Surgery Technologies market. The company incorporates evolving surgical advancements, visualization technologies and procedure-focused engineering into its development process to support changing healthcare expectations. Continuous attention to system functionality, surgical precision and minimally invasive treatment support helps New Wave Endo-Surgical remain aligned with advancements in modern surgical care. This commitment to innovation supports the company’s long-term focus on advanced operating room technologies.

Q6

Why is New Wave Endo-Surgical relevant to today’s surgical healthcare landscape?

Healthcare providers increasingly seek technologies capable of supporting minimally invasive procedures, enhanced surgical precision and efficient operating workflows. New Wave Endo-Surgical remains relevant because its Endoscopic and Robotic Surgery Technologies are designed to address these priorities through clinically focused innovation and advanced procedural support systems. The company’s emphasis on surgical efficiency, visualization capabilities and minimally invasive treatment alignment supports the evolving needs of healthcare organizations and surgical specialists. Its specialized approach continues to contribute to the advancement of modern surgical technology.

Top Endoscopic and Robotic Surgeries Technology - 2026

Company
New Wave Endo-Surgical

Management
Alexander Gomez, CEO

Description
New Wave Endo-Surgical, led by CEO Alexander Gomez, specializes in innovative accessories for laparoscopic and robotic surgery. The company’s flagship M-Close Kit revolutionizes port site closure with protected needles, preventing hernias and visceral injuries while enabling deep-layer anesthetic delivery to reduce postoperative pain and opioid use. Committed to safety, efficiency, and cost-effectiveness in medtech.